A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
Clinical trial NCT07177859 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07177859
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-11-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.